Which intervention is indicated for a patient with alcoholic ketoacidosis ENA?

Treatment

Prehospital Care

The prehospital care provider has several important tasks. First, the prehospital provider should search for any empty containers near the patient. In addition, a blood sugar level should be obtained on anyone who appears intoxicated. Local protocols and the skill level of the provider dictate additional prehospital care for patients with altered mental status.

Emergency Department Care

As with all emergency patients, initial treatment should focus on the airway, breathing, and circulation. Gastric decontamination is rarely necessary for any of the alcohols. An exception to this may be a patient who presents immediately after ingestion of a toxic alcohol in whom one might reasonably expect to be able to recover a significant amount of the toxin via aspiration through a nasogastric tube.

Treatment of ethanol and isopropanol intoxication is largely supportive. [24] Because of the hemorrhagic gastritis that can follow isopropanol ingestion, H2 blockade or proton-pump inhibitors may be helpful. Hemodialysis, while effective, is rarely indicated, and should only be used in the setting of profound hemodynamic compromise. [5]

Once either methanol or ethylene glycol intoxication are suspected, treatment should be initiated without delay. Fortunately, since both alcohols are metabolized by alcohol dehydrogenase, the treatment is the same, and differentiating which of the two toxic alcohols is responsible is not necessary before implementing treatment. [24]

The primary antidotal treatment of methanol or ethylene glycol involves blocking alcohol dehydrogenase. This enzyme can be inhibited by either ethanol or fomepizole. [25, 26, 27] Toxic alcohol levels are frequently not immediately available. Thus, ideally, if methanol or ethylene glycol poisoning is suspected, the patient should receive a loading dose of fomepizole while the levels are being obtained. Because the next dose of fomepizole is not due for an additional 12 hours, this strategy allows 12 hours for the blood to be processed at a reference laboratory before additional treatment is needed.

Inhibition of alcohol dehydrogenase with ethanol may be substituted for treatment with fomepizole (see below), though studies have highlighted the greater safety of fomepizole as a treatment, when available. [11] In some patients, treatment with fomepizole alone may represent definitive treatment and can prevent the need for hemodialysis. [28]

In addition to blocking alcohol dehydrogenase, significant metabolic acidosis should be treated with sodium bicarbonate infusions. If methanol is suspected, folinic acid should be administered at a dose of 1 mg/kg, with a maximal dose of 50 mg. It should be repeated every 4 hours. If folinic acid is not immediately available, folic acid can be substituted at the same dose.

If ethylene glycol overdose is suspected, the patient should also receive 100 mg of intravenous thiamine every 6 hours and 50 mg of pyridoxine every 6 hours. The purpose of the thiamine and pyridoxine is to shunt metabolism of glyoxylic acid away from oxalate and favor the formation of less toxic metabolites.

In methanol overdose, sodium bicarbonate should be administered liberally, with the goal being to completely reverse the acidosis. Experimental studies suggest that formate is excreted in the kidneys at a much higher rate when the patient is not acidotic. In addition, when the patient is not acidotic, formic acid dissociates to formate at lower rates so that less formate crosses the blood-brain barrier. Thus, in methanol intoxication, correcting the acidosis actually speeds up elimination of the toxic compound and decreases toxicity.

If ethanol is used as an antidote, the recommended target serum concentration is 100-150 mg/dL. Because ethanol inhibits gluconeogenesis, hypoglycemia is common in patients on an ethanol infusion. [29] Hypoglycemia is particularly prevalent in pediatric patients on such drips. Thus, serum glucose levels must be checked frequently, at least every 2 hours. In addition, because it is difficult to attain a steady serum concentration of ethanol, the ethanol level also must be checked frequently, and titrations made.

A 5% or 10% ethanol solution can be made in the pharmacy. If giving ethanol, administer a loading dose of 600 mg/kg, followed by a drip of 66-154 mg/kg/h, with chronic alcoholics requiring doses at the higher end of the scale. Ethanol can be given either intravenously or orally.

In addition to hypoglycemia, additional adverse effects from ethanol infusion include inebriation, CNS depression, pancreatitis, and local phlebitis. Because of the phlebitis that occurs with ethanol infusions, some advocate that ethanol should only be administered via a central venous line.

Ethanol infusions are not only labor intensive, but once the costs of the frequent blood glucose and serum ethanol level assays are accounted for, ethanol antidotal therapy is frequently more expensive than fomepizole. Ethanol has also been associated with more frequent adverse reactions than fomepizole. [30] Thus, because of the lower overall cost and the ease of administration and safety considerations, fomepizole has become the preferred antidote for methanol or ethylene glycol poisoning. [31]

Fomepizole should be administered as a loading dose of 15 mg/kg. Subsequent doses should be at 10 mg/kg every 12 hours for 4 doses. Because fomepizole actually induces its own metabolism after 48 hours of treatment, if additional doses are needed, the dose should be increased to 15 mg/kg. Fomepizole needs to be re-dosed during hemodialysis. The package insert or local poison center can help with the re-dosing strategy. Fomepizole should be continued until the serum ethylene glycol or methanol concentrations are less than 20 mg/dL.

Hemodialysis is frequently required in patients with significant methanol or ethylene glycol ingestions. [24, 28] Indications for hemodialysis include the following:

  • Arterial pH < 7.10

  • A decline of >0.05 in the arterial pH despite bicarbonate infusion

  • pH < 7.3 despite bicarbonate therapy

  • Rise in serum creatinine level by 90 mmol/L

  • Initial plasma methanol or ethylene glycol concentration ≥50 mg/dL

A number of case reports suggest that hemodialysis should be considered in the treatment of severe alcohol intoxication with serum ethanol levels > 450 mg/dL. Close monitoring is required when administering hemodialysis to patients with alcohol use disorder as alcohol withdrawal syndrome could be triggered by the rapid elimination of ethanol. [32]

Patients with ethanol intoxication can usually be observed until they are no longer clinically intoxicated and then discharged. Patients with isopropanol ingestion may require observation in the hospital.  Patients with significant ingestions of toxic alcohols require hospital admission in a closely monitored setting such as the intensive care unit. Patients who are alcoholics may be at risk of alcohol withdrawal if admitted to the hospital. Patients with known or suspected methanol or ethylene glycol intoxication should be monitored closely, probably in an intensive care unit.

Consultations

For patients with ethanol intoxication who appear to have issues with dependence or abuse, consider referral to an alcohol detoxification facility. Consult a toxicologist for all known or suspected cases of isopropanol, methanol, or ethylene glycol ingestion. If a toxicologist is not immediately available at the medical center where the patient is located, the regional poison control center can be contacted at (800) 222-1222.

Consult a nephrologist for any known or suspected cases of methanol or ethylene glycol intoxication to assist in the decision making for hemodialysis.

Complications

Ethanol ingestion complications include the following:

  • Hypoglycemia is common. [29]  The etiology is multifactorial but largely related to decreased glycogen stores and malnutrition in children and chronic alcoholics, as well as ethanol’s inhibition of glycogenolysis.

  • Patients with acute intoxication may exhibit "holiday heart," in which dysrhythmias, especially atrial fibrillation, occur following a heavy drinking episode. Ethanol lowers the threshold for developing atrial fibrillation.

  • Cirrhosis, esophageal varices, and erosive gastritis are common in patients who use ethanol on a frequent basis.

Complications of other alcohols include the following:

  • Ingestion of isopropanol is associated with hemorrhagic gastritis.

  • Ingestion of methanol is associated with blindness, acidosis, coma, cardiovascular collapse, and death. [18]

  • Ingestion of ethylene glycol is associated with renal failure, acidosis, coma, cardiovascular collapse, and death. [25]

  1. Ng PCY, Long BJ, Davis WT, Sessions DJ, Koyfman A. Toxic alcohol diagnosis and management: an emergency medicine review. Intern Emerg Med. 2018 Apr. 13 (3):375-383. [QxMD MEDLINE Link].

  2. Jammalamadaka D, Raissi S. Ethylene glycol, methanol and isopropyl alcohol intoxication. Am J Med Sci. 2010 Mar. 339(3):276-81. [QxMD MEDLINE Link].

  3. Hornfeldt CS. A report of acute ethanol poisoning in a child: mouthwash versus cologne, perfume and after-shave. J Toxicol Clin Toxicol. 1992. 30(1):115-21. [QxMD MEDLINE Link].

  4. Martz W. A lethal ingestion of a household cleaner containing pine oil and isopropanol. J Anal Toxicol. 2010 Jan-Feb. 34(1):49-52. [QxMD MEDLINE Link].

  5. Slaughter RJ, Mason RW, Beasley DM, Vale JA, Schep LJ. Isopropanol poisoning. Clin Toxicol (Phila). 2014 Jun. 52(5):470-8. [QxMD MEDLINE Link].

  6. ATSDR. Methanol toxicity. Agency for Toxic Substances and Disease Registry. Am Fam Physician. 1993 Jan. 47(1):163-71. [QxMD MEDLINE Link].

  7. Aufderheide TP, White SM, Brady WJ, et al. Inhalational and percutaneous methanol toxicity in two firefighters. Ann Emerg Med. 1993 Dec. 22(12):1916-8. [QxMD MEDLINE Link].

  8. Coulter CV, Farquhar SE, McSherry CM, Isbister GK, Duffull SB. Methanol and ethylene glycol acute poisonings - predictors of mortality. Clin Toxicol (Phila). 2011 Dec. 49(10):900-6. [QxMD MEDLINE Link].

  9. Choi JH, Lee SK, Gil YE, Ryu J, Jung-Choi K, Kim H, et al. Neurological Complications Resulting from Non-Oral Occupational Methanol Poisoning. J Korean Med Sci. 2017 Feb. 32 (2):371-376. [QxMD MEDLINE Link]. [Full Text].

  10. Cascallana JL, Gordo V, Montes R. Severe necrosis of oesophageal and gastric mucosa in fatal methanol poisoning. Forensic Sci Int. 2012 Mar 5. [QxMD MEDLINE Link].

  11. [Guideline] Caravati EM, Erdman AR, Christianson G, Manoguerra AS, Booze LL, Woolf AD, et al. Ethylene glycol exposure: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2005. 43 (5):327-45. [QxMD MEDLINE Link].

  12. Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brooks DE, Dibert KW, et al. 2019 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 37th Annual Report. Clin Toxicol (Phila). 2020 Dec. 58 (12):1360-1541. [QxMD MEDLINE Link]. [Full Text].

  13. Kanny D, Brewer RD, Mesnick JB, Paulozzi LJ, Naimi TS, Lu H. Vital signs: alcohol poisoning deaths - United States, 2010-2012. MMWR Morb Mortal Wkly Rep. 2015 Jan 9. 63 (53):1238-42. [QxMD MEDLINE Link]. [Full Text].

  14. Anderson P. WHO Reports 3 Million Alcohol-Related Deaths in 2016. Medscape Medical News. Available at https://www.medscape.com/viewarticle/902614. September 27, 2018; Accessed: October 2,2018.

  15. Global status report on alcohol and health 2018. World Health Organization. Available at http://www.who.int/substance_abuse/publications/global_alcohol_report/gsr_2018/en/. Accessed: October 2, 2018.

  16. Richards GC. Alcohol-based hand sanitisers: a warning to mitigate future poisonings and deaths. BMJ Evid Based Med. 2020 Dec 1. [QxMD MEDLINE Link]. [Full Text].

  17. Collister D, Duff G, Palatnick W, Komenda P, Tangri N, Hingwala J. A Methanol Intoxication Outbreak From Recreational Ingestion of Fracking Fluid. Am J Kidney Dis. 2017 May. 69 (5):696-700. [QxMD MEDLINE Link].

  18. Yip L, Bixler D, Brooks DE, Clarke KR, Datta SD, Dudley S Jr, et al. Serious Adverse Health Events, Including Death, Associated with Ingesting Alcohol-Based Hand Sanitizers Containing Methanol - Arizona and New Mexico, May-June 2020. MMWR Morb Mortal Wkly Rep. 2020 Aug 14. 69 (32):1070-1073. [QxMD MEDLINE Link]. [Full Text].

  19. Food and Drug Administration. FDA advises consumers not to use hand sanitizer products manufactured by Eskbiochem. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-consumers-not-use-hand-sanitizer-products-manufactured-eskbiochem. June 19, 2020; Accessed: January 2, 2021.

  20. Barceloux DG, Bond GR, Krenzelok EP, et al. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002. 40(4):415-46. [QxMD MEDLINE Link].

  21. Krahn J, Khajuria A. Osmolality gaps: diagnostic accuracy and long-term variability. Clin Chem. 2006 Apr. 52(4):737-9. [QxMD MEDLINE Link].

  22. Brent J. Fomepizole for ethylene glycol and methanol poisoning. N Engl J Med. 2009 May 21. 360(21):2216-23. [QxMD MEDLINE Link].

  23. Hanouneh M, Chen TK. Calcium Oxalate Crystals in Ethylene Glycol Toxicity. N Engl J Med. 2017 Oct 12. 377 (15):1467. [QxMD MEDLINE Link]. [Full Text].

  24. Kraut JA, Kurtz I. Toxic alcohol ingestions: clinical features, diagnosis, and management. Clin J Am Soc Nephrol. 2008 Jan. 3(1):208-25. [QxMD MEDLINE Link].

  25. Brent J, McMartin K, Phillips S, et al. Fomepizole for the treatment of ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group. N Engl J Med. 1999 Mar 18. 340(11):832-8. [QxMD MEDLINE Link].

  26. Brent J, McMartin K, Phillips S, et al. Fomepizole for the treatment of methanol poisoning. N Engl J Med. 2001 Feb 8. 344(6):424-9. [QxMD MEDLINE Link].

  27. Burns MJ, Graudins A, Aaron CK, et al. Treatment of methanol poisoning with intravenous 4-methylpyrazole. Ann Emerg Med. 1997 Dec. 30(6):829-32. [QxMD MEDLINE Link].

  28. Megarbane B, Borron SW, Baud FJ. Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med. 2005 Feb. 31(2):189-95. [QxMD MEDLINE Link].

  29. Lepik KJ, Levy AR, Sobolev BG, Purssell RA, DeWitt CR, Erhardt GD. Adverse drug events associated with the antidotes for methanol and ethylene glycol poisoning: a comparison of ethanol and fomepizole. Ann Emerg Med. 2009 Apr. 53(4):439-450.e10. [QxMD MEDLINE Link].

  30. Thanacoody RH, Gilfillan C, Bradberry SM, Davies J, Jackson G, Vale AJ, et al. Management of poisoning with ethylene glycol and methanol in the UK: a prospective study conducted by the National Poisons Information Service (NPIS). Clin Toxicol (Phila). 2016. 54 (2):134-40. [QxMD MEDLINE Link].

  31. Ghannoum M, Hoffman RS, Mowry JB, Lavergne V. Trends in toxic alcohol exposures in the United States from 2000 to 2013: a focus on the use of antidotes and extracorporeal treatments. Semin Dial. 2014 Jul. 27(4):395-401. [QxMD MEDLINE Link].

  32. Driscoll D, Bleecker G, Francis J, Jaberi A. Acute Hemodialysis for Treatment of Severe Ethanol Intoxication. Kidney Med. 2020 Nov-Dec. 2 (6):793-796. [QxMD MEDLINE Link]. [Full Text].

Which intervention is indicated for a patient with alcoholic ketoacidosis ENA?

Which intervention is indicated for a patient with alcoholic ketoacidosis ENA?

Author

Michael D Levine, MD Assistant Professor, Department of Emergency Medicine, Section of Medical Toxicology, Keck School of Medicine of the University of Southern California

Michael D Levine, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Emergency Physicians, American College of Medical Toxicology, American Medical Association, Phi Beta Kappa, Society for Academic Emergency Medicine, Emergency Medicine Residents' Association

Disclosure: Nothing to disclose.

Coauthor(s)

Specialty Editor Board

John T VanDeVoort, PharmD Regional Director of Pharmacy, Sacred Heart and St Joseph's Hospitals

John T VanDeVoort, PharmD is a member of the following medical societies: American Society of Health-System Pharmacists

Disclosure: Nothing to disclose.

Chief Editor

Jeter (Jay) Pritchard Taylor, III, MD Assistant Professor, Department of Surgery, University of South Carolina School of Medicine; Attending Physician / Clinical Instructor, Compliance Officer, Department of Emergency Medicine, Prisma Health Richland Hospital

Jeter (Jay) Pritchard Taylor, III, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, Columbia Medical Society, Society for Academic Emergency Medicine, South Carolina College of Emergency Physicians, South Carolina Medical Association

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Employed contractor - Chief Editor for Medscape.

Additional Contributors

Jeffrey Glenn Bowman, MD, MS Consulting Staff, Highfield MRI

Disclosure: Nothing to disclose.

Asim Tarabar, MD Assistant Professor, Director, Medical Toxicology, Department of Emergency Medicine, Yale University School of Medicine; Consulting Staff, Department of Emergency Medicine, Yale-New Haven Hospital

Disclosure: Nothing to disclose.

Which intervention is indicated for a patient with alcoholic ketoacidosis?

Alcoholic ketoacidosis causes nausea, vomiting, and abdominal pain. Diagnosis is by history and findings of ketoacidosis without hyperglycemia. Treatment is IV saline solution and dextrose infusion.

Which intervention is indicated to treat a patient with diabetic ketoacidosis?

Insulin therapy. Insulin reverses diabetic ketoacidosis. In addition to fluids and electrolytes, insulin is given, usually through a vein.

Which disorder may result from diabetic ketoacidosis treatment?

Low potassium, also known as hypokalemia. The fluids and insulin used to treat diabetic ketoacidosis can cause the potassium level to drop too low. A low potassium level can affect the heart, muscles and nerves.

Which intervention is indicated for treating central diabetes insipidus?

Central diabetes insipidus. Typically, this form is treated with a synthetic hormone called desmopressin (DDAVP, Nocdurna). This medication replaces the missing anti-diuretic hormone (ADH) and decreases urination. You can take desmopressin in a tablet, as a nasal spray or by injection.